{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:18:42Z","timestamp":1791389922670,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijid.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T19:14:20Z","timestamp":1550862860000},"page":"S29-S31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S","title":["Latent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritis"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-9087","authenticated-orcid":false,"given":"Cesar","family":"Ugarte-Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo M.","family":"Carrillo-Larco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijid.2019.02.018_bib0005","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3899\/jrheum.150057","article-title":"The risk of tuberculosis in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha antagonist: a metaanalysis of both randomized controlled trials and registry\/cohort studies","volume":"42","author":"Ai","year":"2015","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.ijid.2019.02.018_bib0010","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/infdis\/jiv568","article-title":"Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms","volume":"213","author":"Boillat-Blanco","year":"2016","journal-title":"J Infecti Dis"},{"issue":"1","key":"10.1016\/j.ijid.2019.02.018_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.ajkd.2018.07.014","article-title":"Screening for latent tuberculosis infection in migrants with CKD: a cost-effectiveness analysis","volume":"73","author":"Campbell","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijid.2019.02.018_bib0020","doi-asserted-by":"crossref","first-page":"8909834","DOI":"10.1155\/2017\/8909834","article-title":"Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics","volume":"2017","author":"Cantini","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"5","key":"10.1016\/j.ijid.2019.02.018_bib0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1525-139X.2010.00784.x","article-title":"Inflammation in end-stage renal disease\u2014what have we learned in 10 years?","volume":"23","author":"Carrero","year":"2010","journal-title":"Semin Dial"},{"issue":"5","key":"10.1016\/j.ijid.2019.02.018_bib0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/00365548.2014.885657","article-title":"Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls","volume":"46","author":"Faurholt-Jepsen","year":"2014","journal-title":"Scand J Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2019.02.018_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.ijid.2019.02.018_bib0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/trstmh\/trx015","article-title":"Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia","volume":"111","author":"Koesoemadinata","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.ijid.2019.02.018_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002072","article-title":"Glycemic control and the risk of tuberculosis: a cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.ijid.2019.02.018_bib0050","first-page":"719","article-title":"Diabetes mellitus and latent tuberculosis infection: a systematic review and metaanalysis","volume":"64","author":"Lee","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2019.02.018_bib0055","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.5588\/ijtld.18.0045","article-title":"Convergence of non-communicable diseases and tuberculosis: a two-way street?","volume":"22","author":"Magee","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"10.1016\/j.ijid.2019.02.018_bib0060","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/cid\/cix632","article-title":"Glycemic control and the prevalence of tuberculosis infection: a population-based observational study","volume":"65","author":"Martinez","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2019.02.018_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.arcmed.2015.03.009","article-title":"Associated risk factors for latent tuberculosis infection in subjects with diabetes","volume":"46","author":"Martinez-Aguilar","year":"2015","journal-title":"Arch Med Res"},{"issue":"4","key":"10.1016\/j.ijid.2019.02.018_bib0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jinf.2018.06.003","article-title":"Risk factors associated with the development of active tuberculosis among patients with advanced chronic kidney disease","volume":"77","author":"Moran","year":"2018","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.ijid.2019.02.018_bib0075","first-page":"681","article-title":"An update on the management of latent tuberculosis infection and active disease in patients with chronic kidney disease","volume":"127","author":"Myall","year":"2017","journal-title":"Pol Arch Intern Med"},{"issue":"5","key":"10.1016\/j.ijid.2019.02.018_bib0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2213-8587(15)00042-X","article-title":"Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study","volume":"3","author":"Pan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ijid.2019.02.018_bib0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2015.12.026","article-title":"Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines","volume":"79","author":"Pavan Kumar","year":"2016","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.ijid.2019.02.018_bib0090","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3904\/kjim.2016.222","article-title":"Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases","volume":"33","author":"Pyo","year":"2018","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.ijid.2019.02.018_bib0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.kint.2016.01.034","article-title":"Tuberculosis and chronic kidney disease: an emerging global syndemic","volume":"90","author":"Romanowski","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ijid.2019.02.018_bib0100","first-page":"1","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"263","key":"10.1016\/j.ijid.2019.02.018_bib0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2019.02.018_bib0110","series-title":"The end TB strategy: global strategy and targets for tuberculosis prevention, care and controlafter 2015","author":"WHO","year":"2014"},{"key":"10.1016\/j.ijid.2019.02.018_bib0115","series-title":"Global tuberculosis report","author":"WHO","year":"2018"},{"key":"10.1016\/j.ijid.2019.02.018_bib0120","series-title":"Latent TB infection: updated and consolidated guidelines for programmatic management","author":"WHO","year":"2018"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T17:12:37Z","timestamp":1552065157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219300827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":24,"alternative-id":["S1201971219300827"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.018","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}